(range 27-62 years) and of the controls was 41.5 years (range In IgA nephropathy, lectin binding assays [2] [3] [4] and 17-62 years). This study was approved by the Ethical matrix-assisted laser desorption mass spectroscopy [11] Committee of Leicestershire Health Authority.
have indicated significant differences in the hinge region O-glycans which may have structural and functional implications relevant to the pathogenesis of the Preparation of peripheral blood mononuclear cells disease [6 ] .
(PBMCs) and serum IgA1 This closely located cluster of O-glycans is large in PBMCs were isolated from the blood by density gradient comparison to the protein backbone, and carries a centrifugation. IgA1 was purified from the serum of the same high negative charge, due to sialylation of the sugars. subjects by affinity chromatography on jacalin-agarose as Series of O-glycans tend to confer an extended structure previously described [2] . of IgA1 catabolism is via the hepatic asialoglycoprotein tosamine, and which shows increased affinity for IgA1 in receptor, which has high affinity for the O-glycans IgAN [2] . The binding of biotinylated VV lectin to serum [13] ; impairment of this process may lead to failure of IgA1 was measured in our published ELISA-type assay [2] . IgA1 clearance from the circulation. Lastly, enhanced Briefly, duplicate wells of immunoplates were saturated with or compromised ligation of leucocyte and mesangial IgA1 samples, and after washing with PBS containing 0.3 M cell IgA receptors could be involved in the development NaCl and 0.1% Tween 20, excess binding sites were blocked with 5mg/ml oxidised glutathione in PBS. The plates were of glomerular inflammation.
washed again and 1 mg/ml biotinylated VV lectin applied.
Defective O-glycosylation may be post-translational, After further washing, bound VV lectin was detected with but it is important to exclude an altered amino acid could modify the amino acid sequence, we compared the a1 hinge region DNA nucleotide sequence in IgAN DNA extraction, PCR, and sequencing and controls. We also synthesised hinge region cDNA by reverse transcription from mRNA and compared Total cellular DNA was extracted from the PBMCs of six the sizes of these transcripts in IgAN and controls, to patients and seven controls using TRIzol-LS reagent (Life look for evidence for abnormally transcribed mRNA Technologies, Paisley, UK ). A portion of the a1 gene conspecies. The O-glycosylation of serum IgA1 from the taining the hinge region (illustrated in Figure 2 ) was amplified same subjects was assessed by lectin binding.
by PCR using the primers 5∞-AAT CCC AGC CAG GAT GTG AC −3∞ (sense) and 5∞-AGG CAG CAG TGC AAG TGA AG −3∞ (anti-sense). After a hot start at 98°C for 10 min and cooling to 72°C, 1U Thermus aquaticus poly-
Subjects and methods
merase was added and the PCR carried out with four cycles of denaturation at 95°C for 1 min 30 s, annealing at 63.5°C Materials for 1 min, and extension at 72°C for 1 min, followed by 30 cycles of denaturation at 95°C for 1 min, annealing at 63.5°C All chemicals were purchased from Sigma Chemical Co, for 1 min and extension at 72°C for 1 min. Poole, UK, except where otherwise specified.
The PCR-amplified products were separated by electrophoresis through 1.5% agarose, and each band excised and purified using the silica matrix-based SephaglasTM Bandprep Subjects kit (Pharmacia, St Albans, UK ). For sequencing, DNA was synthesized using the ABI PRISMTM Dye Terminator Cycle Venous blood was obtained with informed consent from 10 patients (9 male) with renal-biopsy-proven IgAN and 10 Sequencing Ready Reaction Kit (Perkin Elmer, Beaconsfield, UK ). The extension products were precipitated with healthy age, gender-and race-matched controls recruited from hospital staff. The median age of the patients was 47.5 years ethanol, separated by 6% denaturing polyacrylamide gel electrophoresis, and analysed using an automated sequencer control samples. The nucleotides from positions 693 (Perkin Elmer, Beaconsfield, UK ).
to 774 of the published sequence [8] were sequenced; this region contains the hinge and is illustrated in Figure 2 . The genomic DNA for this region, spanning mRNA extraction, cDNA synthesis, and size analysis 81 nucleotides, was identical in all 13 subjects and was 100% homologous to the published sequence: RT-PCR amplification of IgA1 hinge region mRNA yielded a band of the expected 349-bp size in all 10 subjects (5 IgAN and 5 controls). The bands obtained Statistics from all individuals were of identical size, as shown in Figure 4 ; with no differences between IgAN and
The binding of VV lectin to IgA1 from IgAN and control groups was compared by Student's t test.
controls.
Discussion Results

O-glycosylation of serum IgA1
In this study we sought an abnormality of the nucleotide sequence or mRNA transcripts of the a1 hinge Serum IgA1 from patients with IgAN showed signific-region. It is important to establish whether such an antly higher binding to VV lectin than control IgA1 abnormality exists, since an altered IgA1 amino (P=0.04) ( Figure 3) , confirming that these patients acid sequence, presenting an altered template for had abnormal IgA1 O-glycosylation.
post-translational O-glycosylation, could account for the potentially pathogenic abnormality of IgA1 a1 hinge region nucleotide sequence in IgAN O-glycosylation described in IgAN.
The group of patients we studied displayed charac-PCR amplification of the IgA1 hinge region from total teristic abnormal IgA1 O-glycosylation, as demoncellular DNA yielded a single band consistent with the strated by the increased binding of VV lectin to their expected 563-bp fragment in all six patient and seven serum IgA1 in comparison to matched controls.
However, there was no difference in the nucleotide sequence of the a1 hinge region from the subjects with IgAN and race and sex-matched controls, and nor was there evidence for any difference in the mRNA Fig. 4 . Agarose gel electrophoresis of RT-PCR products derived from a1 hinge region mRNA. Lanes 1 and 10: wX174 Hae III DNA Fig. 3 . Binding of VV lectin to IgA1 in IgAN (&) and controls (%); size markers. Lanes 2,7,8 and 9: cDNA from control subjects. Lanes 3-6: cDNA from IgAN subjects. Transcripts from all subjects are mean±SEM. VV shows significantly raised binding to serum IgA1 from patients with IgAN (P=0.04), confirming that these patients of identical size (349 bp, arrowed ) and there is no difference between IgAN and controls. display abnormal IgA1 O-glycosylation.
